Skip to main content
Premium Trial:

Request an Annual Quote

HDC Raises Net from Stock Sale to $2.6M

NEW YORK (GenomeWeb News) - Health Discovery Corporation said today it has received more than $450,000 in additional common equity to add to $2.1 million it received last month in a common stock sale.
 
The company said today it has raised a total of $2.55 million in recent investments. Including $2.1 million in existing secured debt it converted into common or preferred stock, it has increased its coffers to $4.7 million.
 
The company said last month it plans to use the new capital to “focus on executing a business plan that features more biomarker discoveries, licensing and development opportunities, and continued enhancement and protection of our valuable patent estate.”
 
“We now have the financial staying power to fully exploit many of our opportunities,” said HDC’s CEO, Stephen Barnhill.
The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.